Evidence map›Paper›PMID 40501794›Full record

ArticlebioRxiv : the preprint server for biology2025

The Mechanism of Histone Ubiquitylation by the ASB9-CUL5 Ubiquitin Ligase.

Calvin P Lin, Nathan H Lee, Francis X Alipranti, Harry Li, Elizabeth A Komives

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Calvin P LinDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, California 92092, USA.ORCID 0000-0002-5916-7011
Nathan H LeeCurrent address: Nathan H. Lee - Department of Biophysics and Biophysical Chemistry, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Francis X AliprantiCurrent address: Francis X. Alipranti - Department of Chemistry, University of Chicago. 5735 S. Ellis Ave., Chicago, IL 60637.
Harry LiDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, California 92092, USA.
Elizabeth A KomivesDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, California 92092, USA.ORCID 0000-0001-5264-3866

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The E3 ligase substrate receptor ankyrin and SOCS box protein 9 (ASB9) was shown to bind over 10 different proteins including metabolic enzymes such as creatine kinase, filament proteins such as vimentin, and histones. In previous work, we characterized the ASB9-Cullin 5 E3 ligase (ASB9-CRL) ubiquitylation of creatine kinase and showed that ubiquitylation required the ring-between-ring ligase, ARIH2. Here we characterize the ASB9-CRL ubiquitylation of histones and show that histones H3 and H4 are polyubiquitylated by the ASB9-CRL whereas histones H2A and H2B are not. Many, but not all lysines in the histones are ubiquitylated suggesting some substrate specificity. Binding experiments show that the ligase-histone interaction is highly electrostatic and the neddylated ASB9-CRL binds with highest affinity. Only free histones are ubiquitylated. When the histones are in nucleosomes or in complex with the chaperone Asf1, they are not ubiquitylated. Only K48 and K63 polyubiquitin chains were observed, suggesting that the ubiquitylation probably drives protein degradation. The presence of ASB9 in specific cell types correlates with situations in which free histones H3 and H4 need to be degraded. In this work, we demonstrate that the ASB9-CRL is the ligase that facilitates degradation of histones H3 and H4. In addition, this work represents the first example of Cullin 5 mediated ubiquitylation that does not require a ring-between-ring "helper" ligase.

Identifiers

PMID40501794
PMCPMC12154916

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.